Navigation Links
Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
Date:9/1/2010

SAN DIEGO, Sept. 1 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced that the Company will present at the following investor conferences:

  • Robert W. Baird 2010 Health Care Conference on Tuesday, September 14, 2010 at 8:30 a.m. Eastern Time at The St. Regis Hotel in New York City.
  • UBS Global Life Sciences Conference 2010 on Tuesday, September 21, 2010 at 10:00 a.m. Eastern Time at the Grand Hyatt New York in New York City.
  • 5th Annual JMP Securities Healthcare Conference on Monday, September 27, 2010 at 9:00 a.m. Eastern Time at The New York Palace in New York City.

  • (Logo:  http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

    (Logo:  http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO)

    Live audio webcasts of these presentations will be accessible on the Company's website at www.optimerpharma.com, under the investors section.  Replays of these presentations will be available at the same location for 30 days after the presentations.

    About Optimer PharmaceuticalsOptimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing hospital specialty products to treat serious infections and address unmet medical needs. Optimer has two late-stage anti-infective product candidates under development. Fidaxomicin is a narrow spectrum antibiotic being developed for the treatment of Clostridium difficile infection (CDI).  In two Phase 3 trials completed by Optimer to study the safety and efficacy of fidaxomicin for the treatment of CDI, fidaxomicin was statistically superior to vancomycin in global cure rate (defined as cure with no recurre
    '/>"/>

    SOURCE Optimer Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
    2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
    3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
    4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
    5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
    6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
    7. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
    8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    10. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... 2014 , Industry professionals ... inaugural Tweetchat taking place in real-time at CPhI ... by UBM Live , announces the launch ... first of its kind global industry-wide Tweetchat for ... chain, aimed to stimulate conversations on key industry ...
    (Date:8/28/2014)... YORK, Aug. 28, 2014 Reportlinker.com announces ... in its catalogue: North America Aesthetic ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html ... Outlook to 2020 Summary GlobalData,s new ... Market Outlook to 2020", provides key market data ...
    (Date:8/28/2014)... 28, 2014 Reportlinker.com announces ... is available in its catalogue: ... Services Industry (U.S.): Analytics, Extensive Financial ... 2021, NAIC 541380 ... Testing Laboratories, Safety and Compliance Services ...
    Breaking Medicine Technology:CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6
    ... , MORRISTOWN, N.J., Dec. 8 In consultation with the ... has begun a voluntary recall of a single product lot ... Cold Formula Liquid Gels. Bayer initiated the recall after ... certain packages within the lot (less than 4 percent) were ...
    ... , WILMINGTON, Del., Dec. 8 AstraZeneca ... in the company,s Medicare Part D prescription savings program will ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) , Prescriptions ... offices under the changes to the AZ&Me(TM) Prescription Savings program ...
    Cached Medicine Technology:Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2AstraZeneca Medicare Part D Patient Assistance Program No Longer Requires Co-Pays 2
    (Date:8/30/2014)... Flagstaff, AZ (PRWEB) August 30, 2014 Jake ... High School while in the Back2Basics Outdoor Adventures ... want to finish high school so I can actually start ... need English and math, and I'm done.” , He has ... the initial Back2Basics program. Most clients choose to continue on ...
    (Date:8/30/2014)... Ohio (PRWEB) August 30, 2014 As 500 ... birth defect when give to pregnant mothers, Wright & Schulte ... Judge Cynthia M. Rufe. The remand in the ... representative of 18 states and are involved in one ... them to have their Zoloft birth defect lawsuit sent back ...
    (Date:8/30/2014)... GA (PRWEB) August 30, 2014 The ... Open Challenge and K.Warrior Search on November 8th, 2014 ... 20 years, these events have introduced many notorious and ... as Strike-Force, IWF and the UFC. , Among ... numerous fighters leave its doors armed with the virtues ...
    (Date:8/30/2014)... Saturday 30 August 2014: The first comprehensive ESC Guidelines ... at ESC Congress 2014 by Task Force Chairpersons Professor ... The "2014 ESC Guidelines on the diagnosis and treatment ... European Heart Journal (1) and on the ... were published in 2001 but they were restricted to ...
    (Date:8/29/2014)... The Enchant Him review that was recently ... is a system that promises to teach ladies how to ... Carrie Engel, who actually is a popular relationship expert and ... the best advices out there, Carrie worked at this program ... new program is a simple to use step by step ...
    Breaking Medicine News(10 mins):Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 2Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 3Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 4Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 5Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 2Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 3Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 4Health News:First comprehensive ESC Guidelines on aortic diseases published 2Health News:First comprehensive ESC Guidelines on aortic diseases published 3Health News:Enchant Him Review Reveals Unique Relationship Tips for Women 2
    ... together explained that they have identified the gene that ... caused by an abnormal build up of iron in ... the PLA2G6 gene, whose mutated forms trigger several genetic ... could also shed light on the nerve cell degeneration ...
    ... Institute finds children who have habit of eating foods high ... ,Therefore, TSI warned parents to be cautious about ... the market, which was concluded after surveying about 270 processed ... was evident that children’s consuming food with highest fat content ...
    ... antidepressants to the REM Sleep Behavior Disorder (RBD). The ... causes //the onset of this disorder at a younger ... where patients act out their dreams, which are often ... medicine specialist, neurologist and study investigator. This acting out ...
    The Indian Institute of Management, Ahmedabad (IIMA) here Monday signed a memorandum of understanding (MoU) with the US-based Duke Corporate Education //CE to offer customised corporate education prog...
    ... More than 25 children have died of suspected encephalitis and ... Muzaffarpur district for the past few days //. ... the spread of the killer disease. The children reported sudden ... bouts of unconsciousness and convulsion leading to their death. ...
    ... childbirth to ease the pain during labor. But such epidurals ... National Patient Safety Agency (NPSA) in response has issued warnings ... that about 200 errors have been committed due a period ... be administered at the base of the spine, but in ...
    Cached Medicine News:Health News:Rare Nerve Disease Causing Gene Identified 2
    ... SmartCycler System is a rapid, real-time thermal ... biological samples. By automating much of the ... individually programmable, it is the fastest, easiest ... on the market. The SmartCycler delivers highly ...
    ... Real-Time PCR System gives you advanced, ... budget sensitivity. , , Four-color detection ... analysis, pathogen quantitation, SNP genotyping, and ... , Powerful, versatile software including ...
    ... detector easily converts any DNA Engine thermal cycler ... it with any of our user-changeable sample blocks. ... allow it to keep pace with the evolving ... standard DNA Engine base units, new or existing. ...
    Mx3000P instrument, notebook computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, H...
    Medicine Products: